E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/19/2006 in the Prospect News Biotech Daily.

Neurocrine names Gorman COO, Coughlin CFO, Hawran to retire

By Lisa Kerner

Charlotte, N.C., Sept. 19 - Neurocrine Biosciences, Inc. appointed executive vice president and chief business officer Kevin C. Gorman to the position of chief operating officer, reporting to Gary Lyons, president and chief executive officer.

Paul W. Hawran, executive vice president and chief financial officer has retired from full time status at the company, but will remain in an advisory capacity through the first quarter of 2007.

Timothy P. Coughlin has been promoted from vice president and controller to vice president and chief financial officer, assuming Paul Hawran's responsibilities.

Neurocrine is a San Diego-based biopharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.